NIH-funded research R01 grant

Intensive outpatient programs to reduce suicide risk after hospital discharge for Medicaid patients

Official title: Examining Intensive Outpatient Programs as a Potential Mechanism to Reduce Suicide Risk During the Post-Hospitalization Period Among Medicaid Recipients

Funded at Yale University · NIH-11412586 · Data updated 2026-11-12

A program that uses short-term intensive outpatient care after discharge to help Medicaid patients stay safe and lower the chance of a suicide attempt or death.

More Suicide research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 11, 2023
Project endJuly 31, 2028
Funding year2026
Award (this year)$476,734
NIH project number5R01MH131528-04
Project IDNIH-11412586 on NIH RePORTER

Who could benefit from this research

Could help

Adults on Medicaid who have recently been discharged from a psychiatric facility and are at high risk for suicide.

Less likely to help

Patients not using or eligible for post-discharge IOP/PHP services may see little to no benefit from this study.

What this research studies

This project looks at whether intensive outpatient or partial hospitalization programs can lower suicide risk for people recently discharged from psychiatric care. It will analyze real-world data to compare those who receive IOP/PHP services with those who do not during the high-risk period after leaving the hospital. The goal is to see if structured, increased support and services in the community can prevent tragic outcomes during the first months after discharge. Findings could guide policy and expansion of these programs to more regions if they show benefit. The study is led by Yale University and focuses on patients in the Medicaid system.

Why it matters

Potential benefit: If successful, the research could support broader access to IOP/PHP services, potentially reducing post-discharge suicides and saving lives.

How similar studies have gone: Some regions already use IOP/PHP with observed benefits, but nationwide evidence is limited and this study seeks to strengthen that evidence.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Wilkinson, Samuel — Yale University
  • Study coordinator: Wilkinson, Samuel

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.